NanOlogy, LLC CEO David J. Arthur Discusses Their PURCISION™ Technology Advancing Intratumoral Therapy to Treat Cancer
CEOCFO interviews NanOlogy, LLC CEO David J. Arthur on Solving Toxicity & Bioavailability Problems when Treating Cancer FORT WORTH, TX, UNITED STATES, February 26, 2026 /EINPresswire.com/ -- CEOCFO Magazine, an independent business and investor …